ArticleExperimental hematology & oncology2025

Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS

Jeffrey Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.